RS51274B - Farmaceutski aerosolni preparat - Google Patents

Farmaceutski aerosolni preparat

Info

Publication number
RS51274B
RS51274B YUP-69/99A YU6999A RS51274B RS 51274 B RS51274 B RS 51274B YU 6999 A YU6999 A YU 6999A RS 51274 B RS51274 B RS 51274B
Authority
RS
Serbia
Prior art keywords
preparation
aerosol
low
mmad
volatile component
Prior art date
Application number
YUP-69/99A
Other languages
English (en)
Serbian (sr)
Inventor
David Lewis
Davis Ganderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS51274(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of YU6999A publication Critical patent/YU6999A/sh
Publication of RS51274B publication Critical patent/RS51274B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YUP-69/99A 1997-06-13 1998-06-10 Farmaceutski aerosolni preparat RS51274B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (2)

Publication Number Publication Date
YU6999A YU6999A (sh) 2000-03-21
RS51274B true RS51274B (sr) 2010-12-31

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-69/99A RS51274B (sr) 1997-06-13 1998-06-10 Farmaceutski aerosolni preparat

Country Status (44)

Country Link
EP (2) EP1219293A3 (enExample)
JP (1) JP4380802B2 (enExample)
KR (1) KR100546239B1 (enExample)
CN (1) CN1138532C (enExample)
AR (1) AR012977A1 (enExample)
AT (1) ATE222751T1 (enExample)
AU (1) AU729966B2 (enExample)
BG (1) BG63906B1 (enExample)
BR (1) BR9805993B1 (enExample)
CA (1) CA2263445C (enExample)
CO (1) CO4940408A1 (enExample)
CZ (1) CZ295521B6 (enExample)
DE (1) DE69807420T3 (enExample)
DK (1) DK0920302T4 (enExample)
DZ (1) DZ2516A1 (enExample)
EA (1) EA001259B1 (enExample)
EE (1) EE03664B1 (enExample)
ES (1) ES2182351T5 (enExample)
GB (1) GB2326334A (enExample)
GE (1) GEP20012462B (enExample)
HR (1) HRP980317B1 (enExample)
HU (1) HU228487B1 (enExample)
ID (1) ID21491A (enExample)
IL (1) IL128484A (enExample)
IN (1) IN189317B (enExample)
IS (1) IS2435B (enExample)
IT (1) IT1293803B1 (enExample)
MA (1) MA26507A1 (enExample)
ME (2) ME00333B (enExample)
MY (1) MY119074A (enExample)
NO (1) NO327775B1 (enExample)
NZ (1) NZ334149A (enExample)
PL (1) PL193721B1 (enExample)
PT (1) PT920302E (enExample)
RS (1) RS51274B (enExample)
SA (1) SA98190821B1 (enExample)
SI (1) SI0920302T2 (enExample)
SK (1) SK284430B6 (enExample)
TN (1) TNSN98087A1 (enExample)
TR (1) TR199900288T1 (enExample)
TW (1) TW555570B (enExample)
UA (1) UA70289C2 (enExample)
WO (1) WO1998056349A1 (enExample)
ZA (1) ZA985136B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
WO2001019342A2 (en) 1999-09-11 2001-03-22 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
ES2234694T3 (es) * 1999-11-23 2005-07-01 Glaxo Group Limited Formulaciones farmaceuticas de salmeterol.
JP2003518484A (ja) * 1999-12-24 2003-06-10 グラクソ グループ リミテッド サルメテロールおよびプロピオン酸フルチカゾンの医薬用エアゾル製剤
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
BR0015884A (pt) 2000-05-22 2003-07-08 Chiesi Farma Spa Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
ATE267591T1 (de) 2001-07-02 2004-06-15 Chiesi Farma Spa Optimierte tobramycin-formulierung zur aerosolbildung
KR100947409B1 (ko) 2002-03-01 2010-03-12 키에시 파르마슈티시 엣스. 피. 에이. 포모테롤 초미세 조성물
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
DE60216242T2 (de) * 2002-06-06 2007-05-24 Chiesi Farmaceutici S.P.A. Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen
WO2004071488A1 (en) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
MXPA05009920A (es) * 2003-03-20 2005-11-04 Boehringer Ingelheim Pharma Formulacion para un inhalador con dosis medida que emplea hidrofluoroalcanos como propulsores.
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1809243B2 (de) 2004-07-02 2022-06-08 Boehringer Ingelheim International GmbH Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
MX2010005036A (es) * 2007-11-07 2010-05-27 Astrazeneca Ab Formulaciones de polvo seco que comprenden derivados del acido ascorbico.
EP2613829B1 (en) * 2010-09-06 2022-06-29 Chiesi Farmaceutici S.p.A. Metered-dose inhaler
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition
EP3436115B1 (en) 2016-03-31 2021-07-28 Chiesi Farmaceutici S.p.A. Aerosol inhalation device
ES2841649T5 (es) * 2016-09-19 2024-04-24 Mexichem Fluor Sa De Cv Composición farmacéutica
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE60226T1 (de) † 1986-03-10 1991-02-15 Kurt Burghart Pharmazeutikum sowie verfahren zu seiner herstellung.
PT84439B (pt) † 1986-03-10 1989-10-04 Burghart Kurt Processo de preparacao de composicoes farmaceuticas a base de nifedipina
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
AU658854B2 (en) † 1990-10-18 1995-05-04 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
SK140493A3 (en) † 1991-06-10 1994-10-05 Schering Corp Non-chlorofluorocarbon aerosol formulations
ATE226067T1 (de) * 1991-06-10 2002-11-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
ES2079210T3 (es) * 1991-12-12 1996-01-01 Glaxo Group Ltd Formulacion farmaceutica de aerosol.
NZ246421A (en) * 1991-12-18 1996-05-28 Minnesota Mining & Mfg Aerosol formulation containing a drug and a propellant and which is substantially free of surfactant
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
EP0759744B1 (en) † 1994-05-13 2001-10-17 Aradigm Corporation Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
AU3453897A (en) * 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
AU726510B2 (en) † 1996-12-04 2000-11-09 Consort Medical Plc Pharmaceutical compositions and devices for their administration
EP1014943B1 (de) † 1997-02-05 2002-06-19 Jago Research Ag Medizinische aerosolformulierungen

Also Published As

Publication number Publication date
NO990594L (no) 1999-04-13
EA001259B1 (ru) 2000-12-25
ZA985136B (en) 1999-01-07
EA199900201A1 (ru) 1999-06-24
CZ46299A3 (cs) 1999-07-14
ID21491A (id) 1999-06-17
HUP0001339A3 (en) 2000-10-30
IS2435B (is) 2008-10-15
JP2000516965A (ja) 2000-12-19
ITMI971798A1 (it) 1999-01-28
ME00333B (me) 2011-02-10
CN1229355A (zh) 1999-09-22
HK1022271A1 (en) 2000-08-04
DE69807420D1 (de) 2002-10-02
GEP20012462B (en) 2001-06-25
IL128484A (en) 2004-09-27
NO990594D0 (no) 1999-02-09
PL331531A1 (en) 1999-07-19
IS4974A (is) 1999-02-11
EE9900055A (et) 1999-08-16
ES2182351T3 (es) 2003-03-01
UA70289C2 (uk) 2004-10-15
MA26507A1 (fr) 2004-12-20
SI0920302T1 (en) 2002-12-31
EP0920302A1 (en) 1999-06-09
TW555570B (en) 2003-10-01
KR20000068171A (ko) 2000-11-25
EE03664B1 (et) 2002-04-15
SI0920302T2 (sl) 2006-10-31
WO1998056349A1 (en) 1998-12-17
SA98190821B1 (ar) 2006-11-19
PL193721B1 (pl) 2007-03-30
EP0920302B2 (en) 2006-06-21
HUP0001339A2 (hu) 2000-09-28
MEP44008A (en) 2011-02-10
DK0920302T4 (da) 2006-10-09
EP1219293A3 (en) 2003-05-28
KR100546239B1 (ko) 2006-01-26
HRP980317B1 (en) 2002-06-30
CA2263445A1 (en) 1998-12-17
DE69807420T2 (de) 2003-05-08
SK284430B6 (sk) 2005-04-01
BR9805993A (pt) 1999-08-31
GB9712434D0 (en) 1997-08-13
NZ334149A (en) 2000-07-28
BG63906B1 (bg) 2003-06-30
BG103221A (en) 1999-09-30
CA2263445C (en) 2008-09-09
IL128484A0 (en) 2000-01-31
MY119074A (en) 2005-03-31
IN189317B (enExample) 2003-02-08
SK17699A3 (en) 1999-07-12
NO327775B1 (no) 2009-09-21
AR012977A1 (es) 2000-11-22
EP0920302B1 (en) 2002-08-28
EP1219293A2 (en) 2002-07-03
PT920302E (pt) 2002-11-29
TNSN98087A1 (fr) 2005-03-15
IT1293803B1 (it) 1999-03-10
DE69807420T3 (de) 2006-11-16
CZ295521B6 (cs) 2005-08-17
DK0920302T3 (da) 2002-12-23
ES2182351T5 (es) 2007-03-16
JP4380802B2 (ja) 2009-12-09
ATE222751T1 (de) 2002-09-15
CN1138532C (zh) 2004-02-18
CO4940408A1 (es) 2000-07-24
AU8626298A (en) 1998-12-30
AU729966B2 (en) 2001-02-15
GB2326334A (en) 1998-12-23
HU228487B1 (en) 2013-03-28
YU6999A (sh) 2000-03-21
TR199900288T1 (xx) 1999-09-21
BR9805993B1 (pt) 2009-05-05
DZ2516A1 (fr) 2004-11-08
HRP980317A2 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
RS51274B (sr) Farmaceutski aerosolni preparat
US8420058B2 (en) Pharmaceutical aerosol composition
US6713047B1 (en) Pharmaceutical aerosol composition containing HFA 227 and HFA 134a
AU774250B2 (en) Pharmaceutical aerosol composition